IDH1 and glioblastoma: By using PAM, we have successfully developed and validated DNA methylation signatures to distinguish LGG IDH mutant from LGG IDH wild-type samples, LGG IDH mutant samples into diffuse astrocytoma and IDH mutant GBM from the IDH WT GBMs.